Navigation Links
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
Date:8/4/2009

ease) in accrued expenses to contract manufacturers - (40,444) Increase (decrease) in deferred revenue (4,111) (5,321) Increase (decrease) in other liabilities (995) (1,215) ---- ------ Net cash used in operating activities $(71,077) $(96,425) Cash flows from investing activities: Purchases of investments (186,016) (334,685) Sales of investments 7,627 28,590 Maturities of investments 221,948 369,337 Transaction costs from Novartis pulmonary asset sale (4,440) Purchases of property and equipment (7,999) (10,349) ------ ------- Net cash provided by investing activities $31,120 $52,893 Cash flows from financing activities: Payments of loan and capital lease obligations (616) (1,151) Proceeds from issuances of common stock 90 383 --- --- Net cash used in financing activities $(526) $(768) ----- ----- Effect of exchange rates on cash and cash equivalents (109) (164) ---- ---- Net decrease in cash and cash equivalents $(40,592) $(44,464) Cash and cash equivalents at beginning of period 155,584 76,293 ------- ------ Cash and cash equivalents at end of period $114,992 $31,829
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Membership in Medicare ... to a Healthcare Business Strategy report released by ... known as Medigap or Med Supp plans, covered ... 2014, a 5.2% increase from 2013. Between 2013 ... by 551,135 covered lives.  Though UnitedHealth was the ...
(Date:5/6/2015)... 2015  LumiThera Inc., a medical device company focused ... ocular disorders and disease, today announced Retired Congressman ... Board to assist in the company,s mission to treat ... was the U.S. Representative for Washington,s ... He is a member of the Democratic Party. His ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced ... Global Strategic Business Report" report to their offering. ... Canada , Japan , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. The global ...
Breaking Medicine Technology:Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... , ABBOTT PARK, Ill., Nov. 12 Nearly one in ... normal and nearly 34 million have low HDL "good" cholesterol ... HDL and trigs, Abbott has launched two Web sites: ... , "Unhealthy high triglyceride and low HDL levels are factors ...
... a leader in fluorescence in vivo imaging from ... new Cat B 750 FAST(TM) imaging agent for ... and therapeutic response in vivo . Cathepsin B ... target in a range of diseases, including atherosclerosis, oncology, and ...
Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 3
(Date:5/6/2015)... Jersey (PRWEB) May 06, 2015 With ... asthma and subject to its potentially dangerous health effects, ... state-wide program – BEAM (Breathe Easier with Asthma Management) ... The program is being funded through a $500,000 foundation ... Jersey (BGCNJ), which is implementing BEAM throughout the state. ...
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement to ... ™ platform. This exciting new SMS platform creates quite ... / Services. Now you can reach out to ... services and ticker symbol through an easy to use ... will provide managed support and services to advance the ...
(Date:5/6/2015)... As Hilo Medical Center progressed ... Model, the hospital looked for new applications that ... processes. The leadership team realized that while many ... patient registration still required patients to apply ink-on-paper ... Stage 7 attestation fast approaching, Hilo looked for ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, ... in Florida while under the influence of Flakka, according to ... released by CBS4’s Peter D’Oench records Doby distraught in a ... around one year old. The drug treatment center in Florida ... named. The residents polled by CBS Miami express concern about ...
(Date:5/6/2015)... Chesapeake, Va. (PRWEB) May 06, 2015 ... hospital in the state of Virginia to acquire ... Vinci® surgical robot. The system upgrade includes enhanced ... many minimally invasive procedures across a wide spectrum ... surgical options, reduced pain and quicker recovery times. ...
Breaking Medicine News(10 mins):Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3
... farmers have launched a new foundation to benefit farmworkers, ... for three programs related to child care, health care ... For its inaugural projects, the Farmworker Community Support ... Health Services and the Redlands Christian Migrant ...
... 2009 in World Journal of Gastroenterology addresses ... Kingdom of Saudi Arabia investigated, for the first time, ... is synthesized mainly in the liver, during the development ... deficiency is a risk factor and should be viewed ...
... the future of the cosmetic surgery industry. The ... the cosmetic surgery industry, conducted its annual Procedural Survey ... non-invasive laser treatments. , Over the past ... in both males (456%) and females (215%) electing to ...
... for Florida Providers JACKSONVILLE, Fla., March ... information network, announced today an expanded partnership with ... affordable health care to families and individuals. With ... to Molina Healthcare via the Availity secure web ...
... Robbins & Myers, Inc. (NYSE: RBN ) ... its regular cash dividend payment of $0.04 per share. ... to shareholders of record as of April 10, 2009.Robbins ... equipment and systems for critical applications in global energy, ...
... Now for Summer Relief! Woodward Laboratories adds a New ... NS Antifungal Treatment Line; Makes Diagnosing Nail Fungus Convenient ... 35 million Americans have nail fungus, but only 2.5 ... at Woodward Laboratories, a leading hand, foot and skin ...
Cached Medicine News:Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 2Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 3Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 4Health News:Long-term L-carnitine supplementation prevents development of liver cancer 2Health News:Record number of patients seek laser treatments to take lightyears off their faces 2Health News:Availity Expands Partnership with Molina Healthcare 2Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 2Health News:Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now 3
An enzyme linked immunosorbent assay (ELISA) for the detection and quantitationof RF IgG isotype in human serum of patients with rheumatoid arthritis....
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
Medicine Products: